Compare CYRX & TCPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CYRX | TCPC |
|---|---|---|
| Founded | 1999 | 2006 |
| Country | United States | United States |
| Employees | 1100 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 421.6M | 407.2M |
| IPO Year | 2008 | 2006 |
| Metric | CYRX | TCPC |
|---|---|---|
| Price | $7.80 | $3.63 |
| Analyst Decision | Strong Buy | Sell |
| Analyst Count | 9 | 2 |
| Target Price | ★ $12.94 | $3.50 |
| AVG Volume (30 Days) | 382.2K | ★ 1.3M |
| Earning Date | 06-04-2026 | 06-01-2026 |
| Dividend Yield | N/A | ★ 22.10% |
| EPS Growth | ★ 156.22 | N/A |
| EPS | ★ 1.40 | N/A |
| Revenue | ★ $176,177,000.00 | N/A |
| Revenue This Year | $9.71 | N/A |
| Revenue Next Year | $9.56 | N/A |
| P/E Ratio | $5.59 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.63 | $3.62 |
| 52 Week High | $11.45 | $8.11 |
| Indicator | CYRX | TCPC |
|---|---|---|
| Relative Strength Index (RSI) | 36.51 | 22.18 |
| Support Level | $6.57 | N/A |
| Resistance Level | $7.88 | $5.99 |
| Average True Range (ATR) | 0.45 | 0.15 |
| MACD | -0.01 | -0.03 |
| Stochastic Oscillator | 11.43 | 2.49 |
CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. It operates in two reportable segments: Life Sciences Services and Life Sciences Products. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.
BlackRock TCP Capital Corp is an externally-managed specialty finance company focused on middle-market lending. Its investment objective is to achieve high total returns through current income and capital appreciation, with an emphasis on principal protection. It seeks to achieve investment objective through investments in debt securities of middle-market companies. The group generates returns through a combination of the receipt of contractual interest payments on debt investments and origination and similar fees, and, to a lesser extent, equity appreciation through options, warrants, conversion rights or direct equity investments.